Skip to Content
Merck
CN
  • Development and validation of RP-HPLC method for simultaneous estimation of glimepiride and sildenafil citrate in rat plasma-application to pharmacokinetic studies.

Development and validation of RP-HPLC method for simultaneous estimation of glimepiride and sildenafil citrate in rat plasma-application to pharmacokinetic studies.

Drug research (2013-07-26)
A S Tripathi, A P Dewani, P G Shelke, R L Bakal, A V Chandewar, P M Mazumder
ABSTRACT

A simple and sensitive method was developed for simultaneous estimation of Glimepiride (GLIM) and Sildenafil citrate (SIL) in rat Plasma by reverse phase high performance liquid chromatography (RP-HPLC). The drug samples were extracted by liquid-liquid extraction with 300 µl of acetonitrile and 5 ml of diethyl ether. Chromatographic separation was achieved on C18 column using methanol: water (85:15 v/v) as mobile phase at a flow rate of 1 ml/min and UV detection at 230 nm. The retention time of GLIM and SIL was found to be 2.5 and 4.0 min respectively with total run time of 7 min. The developed method was validated for accuracy, precision, linearity and recovery. The method was linear and found to be acceptable over the range of 100-12 000 ng/ml. The method was successfully applied for the analysis of rat plasma sample for application to pharmacokinetic.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glimepiride, ≥98% (HPLC), solid
Supelco
Sildenafil solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Glimepiride for system suitability, European Pharmacopoeia (EP) Reference Standard